Clinical Trial Update: HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating ivabradine for heart-rate lowering and respiratory safety in patients with obstructive airway diseases, including asthma and COP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Medical University of Lodz | Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED